Survival and prognostic factors in small cell lung cancer

Medical Oncology

Volumn 27, Issue 1, 2010, Pages 73-81

  Li, Jian ^a   Dai, Chun Hua ^a   Chen, Ping ^a   Wu, Jian Nong ^a   Bao, Quan Lei ^a   Qiu, Hao ^a   Li, Xiao Qin ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Chemotherapy; Outcome; Prognostic factor; Radiotherapy; Small cell lung cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VASCULOTROPIN; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; ESOPHAGITIS; FATIGUE; FEMALE; HUMAN; LOG RANK TEST; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949265005     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9174-3     Document Type: Article

References (28)

1. C Gridelli R De Vivo S Monfardini 2002 Management of small cell lung cancer in the elderly Crit Rev Oncol Hematol 41 79 88 10.1016/S1040-8428(01) 00163-9 10.1016/S1040-8428(01)00163-9 1:STN:280:DC%2BD38%2FntVeqsw%3D%3D 11796233 (Pubitemid 34055731)
2. YJ Chua C Steer D Yip 2004 Recent advances in management of small-cell lung cancer Cancer Treat Rev 30 521 43 10.1016/j.ctrv.2004.06.003 10.1016/j.ctrv.2004.06.003 1:CAS:528:DC%2BD2cXmvFCltro%3D 15325033 (Pubitemid 39157853)
3. G Rosti, et al. 2006 Small cell lung cancer Ann Oncol 17 Suppl 2 ii5 10 10.1093/annonc/mdj910 10.1093/annonc/mdj910 16608983
4. D Spiegelmen, et al. 1989 Prognostic factors in small-cell carcinoma of the lung: an analysis of 1, 521 patients J Clin Oncol 7 344 54
5. M Paesmans, et al. 2000 Prognostic factors for patients with small cell lung carcinoma: Analysis of a series of 763 patients included in 14 consecutive prospective trials with a minimum follow up of 5 years Cancer 89 523 33 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6 1:STN:280:DC%2BD3cvgt1aktQ%3D%3D 10931451 (Pubitemid 30640099)
6. JP Sculier, et al. 1985 Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer J Clin Oncol 3 1349 54 1:STN:280: DyaL28%2FhtVClsw%3D%3D 2995598
7. P Salven T Ruotsalainen K Mattson H Joensuu 1998 High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer Int J Cancer 79 144 6 10.1002/(SICI)1097- 0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T 10.1002/(SICI)1097- 0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T 1:STN:280:DyaK1c3ktlSrtA%3D%3D 9583728 (Pubitemid 28201685)
8. NSB Rawson J Peto 1990 An overview of prognostic factors in small cell lung cancer Br J Cancer 61 597 604 1:STN:280:DyaK3c3jsVKmsQ%3D%3D 2158808
9. U Sagman, et al. 1991 Small-cell carcinoma of the lung: derivation of a prognostic staging system J Clin Oncol 9 1639 49 1:STN:280:DyaK3MzktFGgsw%3D%3D 1651996
10. JJ Ludbrook, et al. 2003 Do age and comorbidity impact treatment allocation and outcome in limited stage small-cell lung cancer ? A community-based population analysis Int J Radiat Oncol Biol Phys 55 1321 30 10.1016/S0360-3016(02)04576-5 12654444 (Pubitemid 36338300)
11. RM Bremnes, et al. 2003 The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5 year follow-up Lung Cancer 39 303 13 10.1016/S0169-5002(02)00508-1 10.1016/S0169-5002(02)00508-1 12609569 (Pubitemid 36279450)
12. K Osterlind HH Hansen M Hansen P Dombernowsky PK Anderson 1986 Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants J Clin Oncol 4 1307 13 1:STN:280:DyaL28zgs12nsQ%3D%3D 3018182
13. S Singh, et al. 2005 Influence of sex on toxicity and treatment outcome in small-cell lung cancer J Clin Oncol 23 850 6 10.1200/JCO.2005.03.171 10.1200/JCO.2005.03.171 15681530 (Pubitemid 46224185)
14. K Fizazi, et al. 1998 Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung cancer Cancer 82 1049 55 10.1002/(SICI)1097-0142(19980315)82:6<1049::AID-CNCR6>3.0.CO;2-9 10.1002/(SICI)1097-0142(19980315)82:6<1049::AID-CNCR6>3.0.CO;2-9 1:STN:280:DyaK1c7msFWksw%3D%3D 9506348 (Pubitemid 28136516)
15. Z Ustuner, et al. 2008 Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients Med Oncol 25 394 9 10.1007/s12032-008-9052-4 10.1007/s12032-008-9052-4 18317954
16. A Sandler 2007 Bevacizumab in non-smll cell lung cancer Clin Cancer Res 13 Suppl 15 4613s 6s 10.1158/1078-0432.CCR-07-0647 10.1158/1078-0432.CCR-07-0647 1:CAS:528:DC%2BD2sXotlKjs74%3D (Pubitemid 47219734)
17. KD Hatzakis, et al. 2002 Prognostic value of serum tumor markers in patients with lung cancer Respiration 69 25 9 10.1159/000049366 10.1159/000049366 1:CAS:528:DC%2BD38XhtFOqsrc%3D 11844959 (Pubitemid 34158384)
18. S Ando M Suzuki N Yamamoto T Iida H Kimura 2004 The prognistic value of both neuron-specifik enolase (NSE) and Cyfra 21-1 in small cell lung cancer Anticancer Res 24 1941 6 1:CAS:528:DC%2BD2cXmsV2jur8%3D 15274381
19. LGM Jorgensen, et al. 1996 Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariate analysis on data from nine centers Br J Cancer 74 463 7 1:STN:280:DyaK28zhs1yksg%3D%3D 8695366
20. M Harding, et al. 1990 Neuron specific enolase (NSE) in small cell lung cancer: a tumor marker of prognostic significance? Br J Cancer 61 605 7 1:STN:280:DyaK3c3jsVKmtg%3D%3D 2158809
21. K Maeda, et al. 1996 Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 77 858 63 10.1002/(SICI)1097- 0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A 10.1002/(SICI)1097- 0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A 1:STN:280: DyaK287osFelsA%3D%3D 8608475 (Pubitemid 26061277)
22. RE Jimenez T Wallis P Tabasezka DW Visseher 2000 Determination of HER-2/neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization Mod Pathol 13 37 45 10.1038/modpathol.3880007 10.1038/modpathol.3880007 1:STN:280: DC%2BD3c7it1Siug%3D%3D 10658908
23. M Fukuoka, et al. 1991 Randomized trial of cyclophosphamide, doxorubicin and vincristine versus cisplatin and etoposide versus alteration of these regimens in small-cell lung cancer J Natl Cancer Inst 83 855 61 10.1093/jnci/83.12.855 10.1093/jnci/83.12.855 1:STN:280:DyaK3M3oslWgtw%3D%3D 1648142
24. BJ Roth, et al. 1992 Randomized study of cyclophosphamide, doxorubicin and vincristine versus etoposide and cisplatin versus alteration of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group J Clin Oncol 10 282 91 1:STN:280: DyaK387itF2nsg%3D%3D 1310103
25. JS Ross JA Fletcher 1998 The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Oncologist 3 237 353 10388110
26. A Potti, et al. 2002 Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma Lung Cancer 36 257 61 10.1016/S0169-5002(01)00488-3 10.1016/S0169-5002(01)00488-3 12009234 (Pubitemid 34497123)
27. P Micke 2001 c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis Int J Cancer 15 474 9 10.1002/ijc.1229 10.1002/ijc.1229 (Pubitemid 32319418)
28. A Auperin, et al. 1999 Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group N Engl J Med 34 476 84 10.1056/NEJM199908123410703 10.1056/NEJM199908123410703 (Pubitemid 29372887)